Signals, Powered By EquityPandit
The health regulator USFDA has provided its final approval to Glenmark Pharma for anti-fungal ointment nystatin and triamcinolone acetonide.
The company has also got the tentative approval for Olmesartan medoxomil that is used for the treatment of high blood pressure.
It has said in a BSE filing that “Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the US Food and Drug Administration (USFDA) for nystatin and triamcinolone acetonide ointment USP, 1,00, 000 units/1 mg per gram.”
